Testis-sparing surgery: Experience in 13 patients with oncological and functional outcomes

Authors

  • Murat Keske University of Health Sciences, affiliated with Kayseri Training and Research Hospital
  • Abdullah Erdem Canda
  • Ali Fuat Atmaca
  • Ozer Ural Cakici
  • Muhammed Ersagun Arslan
  • Davut Kamaci
  • Mevlana Derya Balbay

DOI:

https://doi.org/10.5489/cuaj.5379

Keywords:

Partial orchiectomy, testis sparing surgery, testicular tumor

Abstract

Introduction: We present oncological and functional outcomes of patients who underwent testis-sparing surgery (TSS).

Methods: Overall, 13 patients were included. Mean patient age was 29.9±12.5 years. In five patients, TSS was performed for sequential bilateral testicular tumours. One patient underwent concurrent left radical orchiectomy and right TSS. In eight patients with normal contralateral testis, seven underwent left and one underwent right TSS.

Results: Mean pathological tumour size was 14.6±12.5 mm. Intraoperative frozen section evaluation of the mass was performed in eight patients that revealed benign lesions. No intraoperative tumour bed biopsies were taken in this patient group. Regarding the remaining five patients, intraoperative tumour bed biopsies were taken and testicular intraepithelial neoplasia (TIN) was reported in two (40%) patients; no local testicular radiotherapy was given postoperatively. Tumour pathology was malignant in all but one lesion, including Leydig cell tumour (n=1), seminoma(n=2), embryonal carcinoma (n=1), and adenomatoid tumour (n=1). During 47.2±22.5 months of followup, local recurrence was detected in one patient who underwent radical orchiectomy. No additional local recurrence or systemic metastasis was identified in other patients with malignant lesions. For patients with malignant tumours, of the three patients with a normal preoperative testosterone levels, testosterone level was normal in one patient (with no erectile dysfunction [ED]) and was decreased in two patients (with ED) following TSS. No ED was reported in the nine patients with benign lesions.

Conclusions: In carefully selected cases, TSS appears to be a safe, feasible procedure with adequate cancer control that could preserve sexual function.

Downloads

Download data is not yet available.

Author Biography

Murat Keske, University of Health Sciences, affiliated with Kayseri Training and Research Hospital

Dept of urology

Downloads

Published

2018-08-30

How to Cite

Keske, M., Canda, A. E., Atmaca, A. F., Cakici, O. U., Arslan, M. E., Kamaci, D., & Balbay, M. D. (2018). Testis-sparing surgery: Experience in 13 patients with oncological and functional outcomes. Canadian Urological Association Journal, 13(3). https://doi.org/10.5489/cuaj.5379

Issue

Vol. 13 No. 3 (2019): CUAJ March

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.